Nirsevimab (MEDI8897) is a recombinant human respiratory syncytial virus (RSV) monoclonal antibody with a modified Fc region. Nirsevimab efficiently targets RSV-B with a Kd value of 1.5 nM. Nirsevimab can be used to prevent RSV infection.
CAS Number:
[1989556-22-0]
Target:
MEDI8897
* VAT and and shipping costs not included. Errors and price changes excepted